Paraoxonase 1 (PON1) Peptide
PON1
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits PON1
- PON1 (Paraoxonase 1 (PON1))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-PON1 antibody (Catalog #: ARP41401_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- PON1 (Paraoxonase 1 (PON1))
- Synonymes
- esa Peptide, pon Peptide, pon2 Peptide, MGC53915 Peptide, MGC89222 Peptide, PON1 Peptide, ESA Peptide, MVCD5 Peptide, PON Peptide, Pon Peptide, paraoxonase 2 Peptide, paraoxonase 1 Peptide, pon2 Peptide, PON1 Peptide, Pon1 Peptide
- Sujet
-
PON1 hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. It is capable of hydrolyzing a broad spectrum of organophosphate substrates and a number of aromatic carboxylic acid esters. It may mediate an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation.
Alias Symbols: ESA, PON, MVCD5
Protein Interaction Partner: ALB,APOA1,CLU
Protein Size: 355 - Poids moléculaire
- 39 kDa
- ID gène
- 5444
- NCBI Accession
- NM_000446, NP_000437
- UniProt
- P27169
-
Vous êtes ici:
